Patent details

EP2872145 Title: FUSED BENZAZEPINES FOR TREATMENT OF TOURETTE'S SYNDROME

  • Data
  • Documents

Basic Information

Publication number:
EP2872145
PCT Application Number:
US2013050337
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP138159884
PCT Publication Number:
WO2014012034
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FUSED BENZAZEPINES FOR TREATMENT OF TOURETTE'S SYNDROME
French Title of Invention:
BENZAZÉPINES CONDENSÉES POUR LE TRAITEMENT DU SYNDROME DE LA TOURETTE
German Title of Invention:
KONDENSIERTE BENZAZEPINE ZUR BEHANDLUNG DES TOURETTE-SYNDROMS
SPC Number:

Dates

Filing date:
12/07/2013
Grant date:
09/03/2022
EP Publication Date:
20/05/2015
PCT Publication Date:
16/01/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/03/2022
EP B1 Publication Date:
09/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/07/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/02/2022
 
 

Name:
Emalex Biosciences, Inc.
Address:
330 North Wabash Avenue, Suite 3500, Chicago, IL 60611, United States (US)

History of Owners

From:
02/03/2022
To:
25/02/2022

Name:
Emalex Biosciences, Inc.
Address:
20451 Seneca Meadows Parkway, Germantown, MD 20876, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
07/06/2022
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
CHIPKIN, Richard, E.
Address:
United States (US)

2

Name:
KWAN, Rudolf
Address:
United States (US)

Priority

Priority Number:
201261671044 P
Priority Date:
12/07/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/55; A61P 25/14;

Publication

European Patent Bulletin

1

Issue number:
202210
Publication date:
09/03/2022
Description:
Grant (B1)

2

Issue number:
202215
Publication date:
13/04/2022
Description:
Document reprinted after correction (B8, B9)

3

Issue number:
202213
Publication date:
30/03/2022
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/06/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM